IBio Inc. said June 8 that its number of shares was reduced to about 11.6 million from about 115.9 million through a previously announced reverse stock split.
The 1-for-10 reverse stock split was implemented June 8, and the New York biotechnology company's shares will start trading June 11 on a split-adjusted basis.
IBio said its stock will continue to trade on the NYSE American under the symbol IBIO.
Continental Stock Transfer & Trust Co. acted as transfer agent and exchange agent for the reverse stock split.
